In ClearTrial v2.7, the newest version of the award-winning clinical trial software, ClearTrial introduces Portfolio Planning capability which enables clinical development organizations to roll up protocol-level study plans into portfolio-level forecasts in minutes. The software provides instant visibility to monthly budgets, monthly resource demand, and timelines across a program, business unit, therapeutic indication, region, service provider or any other dimension - a capability unique to the industry.
Chicago (PRWEB) March 3, 2009 -- ClearTrial (www.cleartrial.com), a leading provider of clinical trial software for clinical trial operations planning, budgeting, and outsourcing, announced today that it has released version 2.7 of its market-leading ClearTrial clinical trial software, which helps biopharmaceutical companies and clinical research organizations (CROs) accelerate and improve the planning and execution of their clinical trials. Today, 6 of the top 10 biotech companies and many of the largest companies in the industry rely on ClearTrial software to bring quality treatments to market faster, with less cost and effort.
With ClearTrial Portfolio Planning, available in the Enterprise Edition of ClearTrial v2.7, clinical development organizations can now roll up protocol-level study plans into portfolio-level forecasts in minutes, providing instant visibility to monthly budgets, monthly resource demand, and timelines across a program, business unit, therapeutic indication, region, service provider or any other dimension - a capability unique to the industry. And when protocol-level assumptions change, the software automatically updates the portfolio forecast in seconds.
With ClearTrial Portfolio Planning, clinical trial professionals can:
Key Benefits of ClearTrial Portfolio Planning
For clinical operations, outsourcing, finance, and project/resource management professionals at life sciences organizations, ClearTrial Portfolio Planning offers:
Integrated Roll-up for Increased Accuracy and Speed - The software eliminates errors in the time-consuming re-keying involved with manually rolling up multiple study plans into program- or company-wide forecasts. ClearTrial Portfolio Planning also ensures that planners are using the most current information by automatically updating the portfolio forecast with any changes made to the protocol-level assumptions.
Effortless Cost and Resource Demand Forecasting Across the Organization - Monthly cost and resource demand forecasts enable companies to easily identify areas of heavy FTE utilization, and more proactively hire or contract for additional resources - or modify study start dates to smooth out resource utilization. Planners can instantly see the budget and resource impact of dropping or delaying a study or group of studies, immediately assess the result on hours and fees, by month, of outsourcing all monitoring, and more.
Flexibility to Support Business Objectives and Processes - ClearTrial Portfolio Planning enables the creation of portfolios along any clinical development dimension to:
ClearTrial® is a leading provider of clinical trial software for clinical operations planning, budgeting, and outsourcing. ClearTrial's award-winning software helps pharmaceutical, biotechnology, medical device companies, and CROs expedite the clinical development process without sacrificing quality of results. The company's software products support clinical operations, resource planning, and outsourcing departments with a single solution that promotes speed and consistency, while maintaining flexibility to handle different study requirements. For more information please visit http://www.cleartrial.com.
ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.
Read the full story at http://www.prweb.com/releases/2009/03/prweb2201104.htm.
Copyright©2009 Vocus, Inc.
All rights reserved